Posted inMarket
Rise in Weight-Loss Drug Prescriptions Among US Children Under 12
A recent study reveals an increasing trend of weight-loss drug prescriptions for children under 12 in the US, raising important medical discussions.
Posted inMarket
Eli Lilly and the Massive Incretin Market Opportunity
Explore Eli Lilly's massive presence in the incretin market and analyze whether future stock growth and upside potential remain strong.
Posted inBusiness Insights
FDA Advisory Panel Endorses Broader Peptide Access, Igniting Concerns Over Compounding Pharmacy Boom
A Food and Drug Administration (FDA) advisory panel voted this week to endorse expanded access to therapeutic peptides through compounding pharmacies, a decision that health experts warn could spark an…
Posted inBusiness Insights
Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
